In vitro fertilization treatments with the use of clomiphene citrate or letrozole

Fertility and Sterility

Volumn 108, Issue 4, 2017, Pages 568-571

  Haas, Jigal ^a   Casper, Robert F ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

clomiphene citrate; controlled ovarian hyperstimulation; estrogen; Letrozole; minimal stimulation

Indexed keywords

CLOMIFENE CITRATE; ESTRADIOL; GONADOTROPIN; INTEGRIN; LETROZOLE; CLOMIFENE; FERTILITY PROMOTING AGENT; NITRILE; TRIAZOLE DERIVATIVE;

EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; HUMAN; IN VITRO FERTILIZATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; ADVERSE EFFECTS; COMBINATION DRUG THERAPY; FEMALE; INFERTILITY, FEMALE; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PROCEDURES;

CLOMIPHENE; DRUG THERAPY, COMBINATION; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; NITRILES; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; TRIAZOLES;

EID: 85030128200     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2017.08.017     Document Type: Review

References (36)

1. Fauser, B.C., Nargund, G., Andersen, A.N., Norman, R., Tarlatzis, B., Boivin, J., et al. Mild ovarian stimulation for IVF: 10 years later. Hum Reprod 25 (2010), 2678–2684.
2. Gleicher, N., Weghofer, A., Barad, D.H., A case-control pilot study of low-intensity IVF in good-prognosis patients. Reprod Biomed Online 24 (2012), 396–402.
3. Siristatidis, C., Dafopoulos, K., Vrantza, T., Salamalekis, G., Basios, G., Vogiatzi, P., et al. Mild versus conventional antagonist ovarian stimulation protocols in expected normal responders undergoing IVF/ICSI: a case-control study. Gynecol Endocrinol, 2017, 1–4.
4. Karimzadeh, M.A., Ahmadi, S., Oskouian, H., Rahmani, E., Comparison of mild stimulation and conventional stimulation in ART outcome. Arch Gynecol Obstet 281 (2010), 741–746.
5. Ferraretti, A.P., Gianaroli, L., Magli, M.C., Devroey, P., Mild ovarian stimulation with clomiphene citrate launch is a realistic option for in vitro fertilization. Fertil Steril 104 (2015), 333–338.
6. Toftager, M., Bogstad, J., Lossl, K., Praetorius, L., Zedeler, A., Bryndorf, T., et al. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols. Hum Reprod 32 (2017), 556–567.
7. Oride, A., Kanasaki, H., Miyazaki, K., Comparison of human menopausal gonadotropin stimulation with and without clomiphene for in-vitro fertilisation in poor-responders. J Obstet Gynaecol 35 (2015), 163–167.
8. Revelli, A., Chiado, A., Dalmasso, P., Stabile, V., Evangelista, F., Basso, G., et al. “Mild” vs. “long” protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial. J Assist Reprod Genet 31 (2014), 809–815.
9. Song, D., Shi, Y., Zhong, Y., Meng, Q., Hou, S., Li, H., Efficiency of mild ovarian stimulation with clomiphene on poor ovarian responders during IVFICSI procedures: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 204 (2016), 36–43.
10. Siristatidis, C., Salamalekis, G., Dafopoulos, K., Basios, G., Vogiatzi, P., Papantoniou, N., Mild versus conventional ovarian stimulation for poor responders undergoing IVF/ICSI. In Vivo 31 (2017), 231–237.
11. Palomba, S., Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab 100 (2015), 1742–1747.
12. Tatsumi, T., Jwa, S.C., Kuwahara, A., Irahara, M., Kubota, T., Saito, H., No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology. Hum Reprod 32 (2017), 125–132.
13. Diamond, M.P., Legro, R.S., Coutifaris, C., Alvero, R., Robinson, R.D., Casson, P., et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility. N Engl J Med 373 (2015), 1230–1240.
14. Quinn, M.M., Cakmak, H., Letourneau, J.M., Cedars, M.I., Rosen, M.P., Response to ovarian stimulation is not impacted by a breast cancer diagnosis. Hum Reprod 32 (2017), 568–574.
15. Mai, Q., Hu, X., Yang, G., Luo, Y., Huang, K., Yuan, Y., et al. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial. Am J Obstet Gynecol 216 (2017), 42.e1–42.e10.
16. Goldrat, O., Gervy, C., Englert, Y., Delbaere, A., Demeestere, I., Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients. Hum Reprod 30 (2015), 2184–2189.
17. Pereira, N., Hancock, K., Cordeiro, C.N., Lekovich, J.P., Schattman, G.L., Rosenwaks, Z., Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytesdagger. Gynecol Endocrinol 32 (2016), 823–826.
18. Mukherjee, S., Sharma, S., Chakravarty, B.N., Letrozole in a low-cost in vitro fertilization protocol in intracytoplasmic sperm injection cycles for male factor infertility: a randomized controlled trial. J Hum Reprod Sci 5 (2012), 170–174.
19. Verpoest, W.M., Kolibianakis, E., Papanikolaou, E., Smitz, J., Van Steirteghem, A., Devroey, P., Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reprod Biomed Online 13 (2006), 166–172.
20. Ecemis, T., Tasci, Y., Caglar, G.S., Controlled ovarian hyperstimulation with sequential letrozole co-treatment in normo/high responders. Gynecol Endocrinol 32 (2016), 206–209.
21. Weil, S., Vendola, K., Zhou, J., Bondy, C.A., Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 84 (1999), 2951–2956.
22. Fabregues, F., Penarrubia, J., Creus, M., Manau, D., Casals, G., Carmona, F., et al. Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. Hum Reprod 24 (2009), 349–359.
23. Bosdou, J.K., Venetis, C.A., Kolibianakis, E.M., Toulis, K.A., Goulis, D.G., Zepiridis, L., et al. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update 18 (2012), 127–145.
24. Jovanovic, V.P., Kort, D.H., Guarnaccia, M.M., Sauer, M.V., Lobo, R.A., Does the addition of clomiphene citrate or letrazole to gonadotropin treatment enhance the oocyte yield in poor responders undergoing IVF?. J Assist Reprod Genet 28 (2011), 1067–1072.
25. Lee, V.C., Chan, C.C., Ng, E.H., Yeung, W.S., Ho, P.C., Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial. Reprod Biomed Online 23 (2011), 380–388.
26. Ozmen, B., Sonmezer, M., Atabekoglu, C.S., Olmus, H., Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocols. Reprod Biomed Online 19 (2009), 478–485.
27. Yarali, H., Esinler, I., Polat, M., Bozdag, G., Tiras, B., Antagonist/letrozole protocol in poor ovarian responders for intracytoplasmic sperm injection: a comparative study with the microdose flare-up protocol. Fertil Steril 92 (2009), 231–235.
28. Garcia-Velasco, J.A., Moreno, L., Pacheco, A., Guillen, A., Duque, L., Requena, A., et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 84 (2005), 82–87.
29. Lazer, T., Dar, S., Shlush, E., Al Kudmani, B.S., Quach, K., Sojecki, A., et al. Comparison of IVF outcomes between minimal stimulation and high-dose stimulation for patients with poor ovarian reserve. Int J Reprod Med, 2014, 2014, 581451.
30. Thomas, K., Thomson, A., Wood, S., Kingsland, C., Vince, G., Lewis-Jones, I., Endometrial integrin expression in women undergoing in vitro fertilization and the association with subsequent treatment outcome. Fertil Steril 80 (2003), 502–507.
31. Lessey, B.A., Castelbaum, A.J., Sawin, S.W., Buck, C.A., Schinnar, R., Bilker, W., et al. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 79 (1994), 643–649.
32. Ganesh, A., Chauhan, N., Das, S., Chakravarty, B., Chaudhury, K., Endometrial receptivity markers in infertile women stimulated with letrozole compared with clomiphene citrate and natural cycles. Syst Biol Reprod Med 60 (2014), 105–111.
33. Miller, P.B., Parnell, B.A., Bushnell, G., Tallman, N., Forstein, D.A., Higdon, H.L. 3rd, et al. Endometrial receptivity defects during IVF cycles with and without letrozole. Hum Reprod 27 (2012), 881–888.
34. Simon, C., Cano, F., Valbuena, D., Remohi, J., Pellicer, A., Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod 10 (1995), 2432–2437.
35. Zhao, J., Xu, B., Zhang, Q., Li, Y.P., Which one has a better obstetric and perinatal outcome in singleton pregnancy, IVF/ICSI or FET?: a systematic review and meta-analysis. Reprod Biol Endocrinol, 14, 2016, 51.
36. Vidal, M., Vellve, K., Gonzalez-Comadran, M., Robles, A., Prat, M., Torne, M., et al. Perinatal outcomes in children born after fresh or frozen embryo transfer: a Catalan cohort study based on 14,262 newborns. Fertil Steril 107 (2017), 940–947.